Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

NCT02784171 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

520

Enrollment

NETWORK

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Cisplatin
DRUG: Pemetrexed
DRUG: Pembrolizumab

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]